MedTrace Logo

Efficacy of Fish Oil Supplementation on Cognition in MCI Patients and the Influence of the APOE4 Allele

NCT00746005 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-01-12

No results posted yet for this study

Summary

To study the short term effects of a pharmacological dose of fish oil on cognitive performance and on cerebral blood flow. Furthermore, we want to investigate whether carriers of the APOEε4 allele respond differently to fish oil treatment compared to non-carriers.

Conditions

Interventions

DIETARY_SUPPLEMENT

fish oil

3 g fish oil (3078 mg) total EPA 1512 mg and total DHA 1026 mg

DIETARY_SUPPLEMENT

placebo, sunflower oil

3 g of sunflower oil

Sponsors & Collaborators

  • Radboud University Medical Center

    collaborator OTHER

  • Wageningen University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-01-31
Completion
2011-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00746005 on ClinicalTrials.gov